| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.10B | 20.36B | 20.28B | 19.66B | 17.99B | 18.30B |
| Gross Profit | 21.10B | 20.36B | 20.28B | 18.94B | 17.83B | 18.30B |
| EBITDA | 0.00 | 0.00 | 0.00 | 11.09B | 10.02B | 0.00 |
| Net Income | 6.73B | 6.54B | 7.10B | 7.12B | 6.16B | 3.58B |
Balance Sheet | ||||||
| Total Assets | 1.30T | 1.23T | 1.11T | 1.09T | 978.86B | 1.04T |
| Cash, Cash Equivalents and Short-Term Investments | 202.66B | 112.99B | 146.44B | 157.53B | 141.89B | 116.27B |
| Total Debt | 231.51B | 121.28B | 150.08B | 134.00B | 78.43B | 130.51B |
| Total Liabilities | 1.23T | 1.16T | 1.04T | 1.02T | 915.18B | 980.99B |
| Stockholders Equity | 71.57B | 69.86B | 69.52B | 65.91B | 63.66B | 61.29B |
Cash Flow | ||||||
| Free Cash Flow | -25.21B | 9.95B | 5.88B | 19.52B | 43.26B | 53.08B |
| Operating Cash Flow | -25.21B | 9.95B | 6.49B | 20.18B | 43.82B | 52.28B |
| Investing Cash Flow | -31.70B | -42.12B | -10.69B | -1.82B | 10.26B | -11.46B |
| Financing Cash Flow | 112.22B | 17.91B | 4.38B | -2.35B | -9.67B | -12.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $65.90B | 9.57 | 14.58% | 3.90% | 7.43% | 30.31% | |
77 Outperform | $80.46B | 10.64 | 9.44% | 1.88% | 17.50% | 49.25% | |
73 Outperform | $126.37B | 10.99 | 18.00% | 3.48% | 7.52% | 10.40% | |
72 Outperform | $70.96B | 16.20 | 9.75% | 4.51% | 2.74% | -11.28% | |
72 Outperform | $77.41B | 11.80 | 11.71% | 4.44% | 2.20% | -0.17% | |
72 Outperform | $163.81B | 10.93 | 12.54% | 1.99% | -15.34% | 16.71% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |